Business Context and Reporting Period
Company: National Healthcare Properties, Inc. (NHP)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2025
Business Overview: NHP is a non-listed REIT owning a diversified portfolio of healthcare-related real estate, specifically Outpatient Medical Facilities (OMFs) and Senior Housing Operating Properties (SHOPs). As of March 31, 2025, the portfolio consisted of 181 properties (including one land parcel) across 30 states, totaling 7.6 million rentable square feet.
Key Corporate Event: The Company consummated an "Internalization" on September 27, 2024, terminating its external advisory agreement and bringing management functions in-house. Consequently, no asset management or property management fees were paid to related parties in Q1 2025, a significant change from the prior year.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue from Tenants | $86,443 | $88,299 |
| Net Loss | $(1,515) | $(15,550) |
| Net Loss Attributable to Common Stockholders | $(5,019) | $(19,000) |
| Net Loss Per Share (Basic & Diluted) | $(0.18) | $(0.67) |
| Net Operating Income (NOI) | $28,903 | $33,154 |
| Cash and Cash Equivalents | $71,383 | $28,670 |
| Total Debt (Gross) | $1,081,814 | $1,150,680 |
| Weighted Average Interest Rate (Total Debt) | 5.40% | N/A |
Liquidity: Total cash, cash equivalents, and restricted cash stood at $126.4 million as of March 31, 2025. The Company maintains a minimum cash balance of $12.5 million per the Barclays OMF Loan Agreement.
Material Changes vs. Prior Period
- Net Loss Improvement: Net loss attributable to common stockholders improved significantly from $19.0 million in Q1 2024 to $5.0 million in Q1 2025. This improvement was driven by a $25.0 million gain on the sale of 12 OMF properties and the elimination of $6.4 million in operating fees to related parties following Internalization.
- Impairment Charges: Impairment charges increased sharply to $11.9 million in Q1 2025 (vs. $0.3 million in Q1 2024). These charges primarily related to two SHOPs and one OMF impaired to their contractual sales prices prior to disposition.
- Revenue Decline: Total revenue decreased by 2.1% to $86.4 million. The OMF segment saw a 11.5% revenue decline due to property dispositions, while the SHOP segment revenue increased by 3.9% due to occupancy gains.
- Debt Reduction: Total gross debt decreased by approximately $69 million, largely due to debt paydowns associated with property dispositions ($68.4 million) and the repayment of a $30.3 million promissory note related to the Internalization.
- Cash Flow: Operating cash flow turned negative at $(21.2) million, compared to positive $2.5 million in the prior year, primarily due to the repayment of the Internalization promissory note. Investing cash flow was positive at $78.0 million due to proceeds from property sales.
Guidance, Outlook, and Risks
- Outlook: Management believes it has sufficient liquidity to meet obligations for the next 12 months. Future liquidity will be funded by cash on hand, operating activities, property dispositions, and potential new financings using unencumbered assets ($427.0 million).
- Capital Expenditures: Q1 2025 CapEx was $5.7 million. Management anticipates a relatively stable quarterly rate for the remainder of 2025.
- Dividends: The Company does not intend to declare further stock dividends on common stock. Preferred stock distributions (Series A and B) continue to be paid quarterly in cash, funded by available cash on hand rather than operating cash flow.
- Risks:
- Interest Rates: Continued high interest rates may adversely impact borrowing terms and tenant/resident ability to pay rent.
- Inflation: Rising labor, insurance, and property tax costs may pressure margins, particularly in the SHOP segment where leases are short-term and lack escalation provisions.
- Internalization: Risks associated with transitioning from external to internal management.
- Unusual Items: The $25.0 million gain on sale of real estate is a non-recurring item. The $11.9 million impairment charge is specific to properties identified for sale.
Investor Verification Checklist
- Dispositions: Verify the timing and proceeds of the 12 OMF sales in Q1 2025 and the subsequent sale of 4 properties (1 OMF, 3 SHOPs) in April 2025.
- Debt Maturities: Review the schedule of debt maturities, noting significant principal payments due in 2026 ($687.6 million) and the maturity of Fannie Mae Master Credit Facilities in November 2026.
- SHOP Performance: Monitor occupancy rates and expense management in the SHOP segment, which contributed $9.4 million to NOI but faced significant impairment charges.
- Liquidity Coverage: Confirm that cash distributions to preferred stockholders ($3.5 million quarterly) remain sustainable given the negative operating cash flow in Q1 2025.
- Internalization Costs: Assess the long-term impact of Internalization on General and Administrative expenses compared to the eliminated advisory fees.